<DOC>
	<DOCNO>NCT02809456</DOCNO>
	<brief_summary>This project test effect nicorandil mitigate lung damage occur side effect radiation therapy lung cancer . Thousands veteran develop lung cancer every year , treat radiation therapy . Studies lung radiation injury laboratory animal show nicorandil , investigator significantly reduce severity lung fibrosis heart toxicity.1,2 Nicorandil FDA approve common use treatment angina . These study advance work human use . Successful mitigation lung radiation damage heart toxicity improve quality life veteran non-veterans treat lung cancer radiation , may also improve cure rate radiation therapy lung cancer .</brief_summary>
	<brief_title>Mitigation Radiation Pneumonitis , Fibrosis Heart Toxicity With Nicorandil Lung Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Radiation Pneumonitis</mesh_term>
	<mesh_term>Nicorandil</mesh_term>
	<criteria>1 . Histologically cytologicallyproven NSCLC ; mixed histology small cell lung carcinoma ( SCLC ) component allow 2 . Patients stage II IV NSCLC receive least 54 Gy total plan thoracic radiation dose eligible ; patient must receive least one cycle chemotherapy concurrently course thoracic radiation ; regimens allow platinum combination either etoposide taxane regardless histology subtype ; platinum pemetrexed patient nonsquamous NSCLC ; patient oligometastatic stage IV cancer eligible receive one line systemic therapy stage IV cancer prior concurrent chemoradiation phase 3 . Patient must CR/PR/SD , 46 week complete last fraction chemotherapy / radiation therapy . 4 . Eastern Cooperative Oncology Group ( ECOG ) performance score 02 time randomization 5 . Absolute neutrophil count ( ANC ) &gt; = 1,500/uL 6 . Platelet count &gt; = 100,000/uL 7 . Hemoglobin &gt; = 9 g/dL 8 . Total bilirubin = &lt; 1.5 time upper limit normal ( ULN ) OR direct bilirubin normal ( per institute standard ) 9 . Aspartate aminotransferase ( AST ) = &lt; 1.5 x ULN ; alanine aminotransferase ( ALT ) AST = &lt; 3 x ULN acceptable liver metastasis 10 . Fertile patient must use adequate contraception 1 . Wholebrain radiotherapy ( WBRT ) &lt; 14 day anticipate start nicorandil/placebo administration 2 . Unable start nicorandil/placebo treatment 4 6 week complete last dose thoracic radiation 3 . Active untreated brain leptomeningeal metastasis ; patient treated central nervous system ( CNS ) metastases , eligible symptom control least 4 week ; dexamethasone allow total daily dose exceed 2 mg 4 . Major injury surgery ( e.g. , craniotomy ) &lt; 28 day start nicorandil/placebo administration ; wound heal prior start therapy 5 . Second malignancy allow long disease require active treatment concomitant systemic cytotoxic chemotherapy , investigational biologic therapy ( e.g. , anticytotoxic Tlymphocyteassociated protein 4 [ CTLA4 ] human epidermal growth factor receptor 2 [ HER2 ] monoclonal antibody ) ; hormonerelated therapy ( e.g. , gonadotrophin release hormone ( LHRH ) agonists , tamoxifen , etc . ) allow 6 . Concurrent uncontrolled illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would increase risk associate study participation and/or limit compliance study requirement 7 . Common Terminology Criteria Adverse Events ( CTCAE ) Grade 2 high proteinuria 8 . Systemic therapy investigational agent administer &lt; 28 day prior treatment nicorandil 9 . Pregnancy breast feeding ; female patient childbearing potential must negative pregnancy test ( betahuman chorionic gonadotropin [ BHCG ] test urine serum ) prior commence study treatment 10 . Creatinine &gt; 1.5 x ULN creatinine clearance level ( CrCL ) &lt; 45 mL/min 11 . Centrally locate tumor radiographic evidence ( compute tomography [ CT ] magnetic resonance image [ MRI ] ) local invasion major blood vessel 12. acute myocardial infarction within 2 week percutaneous coronary intervention 13. contraindication treatment nicorandil ( allergy , glaucoma , digestive ulcer , currently take phosphodiesterase5 inhibitor ) 14. bypass restenosis 15 . PCI history 16. hypotension 17. impaired liver function 18. renal insufficiency require hemodialysis 19. pregnancy 20. connective tissue disease 21. life expectancy â‰¤ 12 month 22. leave main coronary artery disease 23. bypass graft lesion lesion unsuitable OCT 24. unwillingness inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>